Alopecia areata, an autoimmune disorder causing hair loss, now has an FDA-approved treatment since June 2022. While some explore home remedies like essential oils, dietary changes, and stress ...

Alopecia areata, it's an autoimmune disease that affects 6.8 million Americans. ... and she noticed that the nape of my neck had a big bald area and pointed it out.

Everyone’s alopecia areata is different. Even though everyone who has it experiences hair loss, it may have many variations, including where, when, and how often you lose your hair. Alopecia ...

Alopecia areata can affect your emotional well-being and your quality of life. Some people even think about suicide. It's normal to be sad or angry when you have a condition that affects your self ...

Jada Pinkett Smith in 2018 confirmed she was diagnosed with alopecia. There are multiple kinds of alopecia, including alopecia areata. Many people with conditions related to alopecia do see their ...

Retrograde alopecia is a form of hair loss characterized by the gradual thinning or recession of hair at the nape of the neck or the sides of the scalp.

What many don’t realize is that alopecia areata often affects more than just scalp hair. Eyebrows, eyelashes, and body hair can all disappear, fundamentally changing how a person looks and feels.

Alopecia areata is the condition affecting Jada Pinkett Smith, who found herself at the center of the Will Smith-Chris Rock conflict at the Oscars ceremony March 27. Dr. Brett King answers FAQs ...

Alopecia areata can arise in childhood, adolescence or adulthood, Dr. Lamb said. People who have the condition tend to lose hair in clumps, she said, causing round bald spots.

Alopecia areata risk also has possible positive correlations with levels of N-acetylarginine (OR, 1.31; 95% CI, 1.03-1.65; P = .025) and 12 additional serum metabolites.

New treatment for teens with alopecia. The FDA approved the once-daily pill called Litfulo, created by pharmaceutical giant Pfizer, for people 12 and up to treat severe alopecia areata, or at ...